Aralez Pharma (ARLZ) Reports Q4 Loss of $0.48/Share

Aralez Pharma (NASDAQ: ARLZ) reported Q4 EPS of ($0.48), versus ($0.40) reported last year. Revenue for the quarter came in at $20 million, versus $6 million reported last year.

GUIDANCE:

Aralez Pharma sees FY2017 revenue of $80-100 million.

For earnings history and earnings-related data on Aralez Pharma (ARLZ) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Innovaro (INV) Misses Q2 EPS by 9c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance